STVN

$15.46+0.11 (+0.72%)

Market OpenAs of Mar 17, 7:06 PM UTC

Stevanato Group S.p.A.

Historical Price

Price (Line)
50-Day SMA
200-Day SMA
Synthesizing Whystock Narrative...
Loading Financials...

Peer Comparison

JNJUNHPFE

Whystock Valuation Model

Calculated using a trailing P/E relative model adjusted by sector ROE and historical growth.
Current Price$15.46
Potential Downside
25.2%
Whystock Fair Value$11.56
Price
UndervaluedFair ValueOvervalued

Fundamentals

SectorHealthcare
IndustryMedical Instruments & Supplies

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide solutions for biopharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. ...

Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$4.22B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
26.66
Beta
Defensive asset. Lower volatility than the S&P 500.
0.57
Div Yield
Strong income play. Yield provides a meaningful total return floor.
41.00%
ROIC
Average efficiency. Growth may require heavy reinvestment.
9.67%
Quick Ratio
Pristine liquidity. Sufficient cash to cover all near-term obligations.
1.25

Recent News

Insider Monkey
Mar 17, 2026

Here’s Why Artisan Small Cap Fund Remains Invested in Stevanato Group (STVN)

Artisan Partners, an investment management company, released its fourth-quarter 2025 investor letter for “Artisan Small Cap Fund”. A copy of the letter can be downloaded here. The Fund seeks to invest in companies that possess franchise characteristics, with strong earnings trajectories, and are trading at a discount to the estimated private market value. Despite strong results […]

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Simply Wall St.
Mar 5, 2026

Is It Time To Reassess Stevanato Group (STVN) After The Recent Share Price Rebound

If you are wondering whether Stevanato Group is attractively priced or just a value trap, you are in the right place to break down what the current share price really reflects. The stock closed at US$17.50 recently, with a 7 day return of 14.4% and a 30 day return of 11.3%, against a weaker backdrop over longer periods including a year to date return of 15.0% decline and a 1 year return of 7.9% decline. That mix of short term strength and longer term weakness has put Stevanato Group back on...

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
GuruFocus.com
Mar 4, 2026

Stevanato Group SpA (STVN) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and ...

Stevanato Group SpA (STVN) reports robust fiscal 2025 performance with significant gains in high-value solutions and GLP-1 market, despite challenges in the engineering segment.

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
MarketBeat
Mar 4, 2026

Stevanato Group Q4 Earnings Call Highlights

Stevanato Group (NYSE:STVN) executives said the company closed fiscal 2025 with “solid” results and entered 2026 with positive momentum, driven by continued strength in its Biopharmaceutical and Diagnostic Solutions (BDS) segment and accelerating demand for high-value products tied to GLP-1 therapie

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Moby
Mar 4, 2026

Stevanato Group S.p.A. Q4 2025 Earnings Call Summary

Moby summary of Stevanato Group S.p.A.'s Q4 2025 earnings call

NEUTRAL
Neutral flow. Standard news cycle with no clear sentiment tilt.